Mindwalk Holdings vs Opus Genetics
Opus Genetics is the larger business, with $14.2m of revenue in fiscal 2025 against $11.3m for Mindwalk Holdings (1.3 times as much). Mindwalk Holdings grew faster (47.8% against 29.1%). Mindwalk Holdings kept more of each dollar of sales as profit: a net margin of -89.7% against -349.3%. Mindwalk Holdings carries less debt relative to equity (0.0% against 7.4%).
| Latest fiscal year | Mindwalk HoldingsHYFT, 2026 | Opus GeneticsIRD, 2025 |
|---|---|---|
| Revenue | $11.3m | $14.2m |
| Revenue growth | 47.8% | 29.1% |
| Net income | −$10.1m | −$49.6m |
| Operating margin | — | -271.9% |
| Net margin | -89.7% | -349.3% |
| Return on equity | -78.5% | — |
| Free cash flow | −$9.3m | −$35.3m |
| Cash | $8.4m | $45.1m |
| Total debt | $0 | $1.1m |
| Debt to equity | 0.0% | 7.4% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 27 |
| Market value | $50.6m | $324m |
| Price vs our value range | — | — |
| Moat score | — | 10 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 2 buys, 23 sales |